Author

Aymen D. Jaafar

Observed name: Aymen Dheyaa Jaafar

Institution: Royal College of Physicians and Surgeons of Glasgow

Observed institutions: Ministry of Health, Royal College of Physicians and Surgeons of Glasgow

ORCID: 0000-0003-3848-375X

Observed ORCID: 0000-0003-3848-375X

OpenAlex ID: A5057301812

Appraising the cost of illness of diabetic retinopathy and diabetic macular edema over the last decade: a systematic review

2025 · Rawaa M Jabbar, Ali Azeez Al-Jumaili, et al. · International Journal of Pharmacy Practice · 5

Quantifying the direct costs of diabetic retinopathy in a mixed healthcare system: a hospital-based study from governmental and patient perspectives

2026 · Rawaa M. Jabbar, Ali Azeez Al-Jumaili, et al. · Cost Effectiveness and Resource Allocation · 2

Macular oedema after uncomplicated phacoemulsification

2022 · Aymen D. Jaafar, Suzan A. Abdulkareem, et al. · African vision and eye health · 2

A Field-Based Cost-Effectiveness Study of Aflibercept and Bevacizumab in Treat-and-Extend Versus Pro Re Nata Protocols for Diabetic Macular Edema in Iraq

2026 · Rawaa M. Jabbar, Ali Azeez Al-Jumaili, et al. · Clinical Drug Investigation

Assessment of Serum Levels of the WNT Pathway Antagonist (Dickkopf-1) in a Sample of Type 2 Diabetic Patients with Retinopathy using Two Groups of Antidiabetics

2022 · Sara A Kadhim, Eman S. Saleh, et al. · International Journal of Drug Delivery Technology

Works count: 5

Citation count: 9

H-index: 2

I10-index: